Peter Sonnenreich

Feature Story

Positive Results Revealed for Atopic Dermatitis Investigational Drug Etrasimod

10/10/2021

Recently presented clinical trial data on investigational drug candidate etrasimod, a novel investigational therapy, shows promise for treating moderate to severe atopic dermatitis.

Recently presented clinical...

10/10/2021

The Dermatologist

Diabetes

How Will Diabetes Trends Affect Wound Clinics in the Future?

03/05/2020

Peter Sonnenreich ;

Lou Savant ;

Natalie Berry ;

Mary Anne Dunkin ;

As the increasing prevalence of diabetes leads to more chronic wounds, how will the wound clinic adjust? Wound care specialists and managed care organizations weigh in on this complex and growing problem.

As the increasing prevalence of...

03/05/2020

Today's Wound Clinic

Partner Approved

Tralokinumab: A New Potential for Atopic Dermatitis

09/11/2020

Peter Sonnenreich ;

New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.

New biologic therapy...

09/11/2020

The Dermatologist

NPF Endorsed Features

Tailoring Treatments for Psoriasis

09/16/2019

Katherine Moody ;

Bassem Wolley ;

Peter Sonnenreich ;

Certain comorbidities—particularly congestive heart failure, tuberculosis, and HIV infection—can affect the type of psoriasis treatment physicians recommend to their patients.

Certain...

09/16/2019

The Dermatologist

Feature Story

Topical JAK Inhibitor Offers Promise for Two Skin Diseases

09/15/2021

Peter Sonnenreich ;

Mary Anne Dunkin ;

A number of emerging therapies involving the JAK-STAT pathway are in the pipeline for immune-mediated inflammatory diseases. One particular Janus kinase inhibitor shows potential for atopic dermatitis and vitiligo.

A number of emerging therapies...

09/15/2021

The Dermatologist

NPF Endorsed Features

Psoriatic Arthritis: A Dermatologist’s Perspective

06/27/2019

Linda Geisler ;

Peter Sonnenreich ;

Katherine Moody ;

Bassem Wolley ;

About 30% of patients with psoriasis will develop this chronic, inflammatory comorbidity. Knowing how to recognize and treat it can help improve patient outcomes.

About 30% of patients with...

06/27/2019

The Dermatologist

Feature Story

Treating Zoster-Associated Pain and Postherpetic Neuralgia

10/12/2021

Mary Anne Dunkin ;

Peter Sonnenreich ;

As many as one in five patients with herpes zoster develops zoster-associated pain and/or postherpetic neuralgia. Physicians share their insights on how they treat the sequelae of herpes zoster in their practice.

As many as one in five patients...

10/12/2021

The Dermatologist